Trial will use 300 volunteers to assess whether jab produces strong immune response in children aged six to 17
The efficacy of the Oxford/AstraZeneca vaccine in children is due to be tested in a new clinical trial beginning this month.
Researchers will use 300 volunteers to assess whether the jab – known as the the ChAdOx1 nCoV-19 vaccine – produces a strong immune response in children aged between six and 17.
Continue reading...from The Guardian https://ift.tt/3tOWADv
